These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 23130962)

  • 1. Circadian rhythms in the efficacy of intravenous alteplase in patients with acute ischemic stroke and middle cerebral artery occlusion.
    Vilas D; Gomis M; Blanco M; Cortés J; Millán M; Pérez de la Ossa N; Dorado L; López-Cancio E; Suñol A; Dávalos A
    Chronobiol Int; 2012 Dec; 29(10):1383-9. PubMed ID: 23130962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of pretreatment ASPECTS scores with tPA-induced arterial recanalization in acute middle cerebral artery occlusion.
    Tsivgoulis G; Saqqur M; Sharma VK; Lao AY; Hoover SL; Alexandrov AV;
    J Neuroimaging; 2008 Jan; 18(1):56-61. PubMed ID: 18190497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with tPA predicts better outcome even if MCA occlusion persists.
    Kablau M; Alonso A; Hennerici MG; Fatar M
    Int J Stroke; 2013 Oct; 8(7):496-502. PubMed ID: 22340025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perfusion computed tomography-guided intravenous thrombolysis for acute ischemic stroke beyond 4.5 hours: a case-control study.
    García-Bermejo P; Calleja AI; Pérez-Fernández S; Cortijo E; del Monte JM; García-Porrero M; Fe Muñoz M; Fernández-Herranz R; Arenillas JF
    Cerebrovasc Dis; 2012; 34(1):31-7. PubMed ID: 22759450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of early arterial reocclusion after tissue plasminogen activator-induced recanalization in acute ischemic stroke.
    Rubiera M; Alvarez-Sabín J; Ribo M; Montaner J; Santamarina E; Arenillas JF; Huertas R; Delgado P; Purroy F; Molina CA
    Stroke; 2005 Jul; 36(7):1452-6. PubMed ID: 15947260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbubble administration accelerates clot lysis during continuous 2-MHz ultrasound monitoring in stroke patients treated with intravenous tissue plasminogen activator.
    Molina CA; Ribo M; Rubiera M; Montaner J; Santamarina E; Delgado-Mederos R; Arenillas JF; Huertas R; Purroy F; Delgado P; Alvarez-Sabín J
    Stroke; 2006 Feb; 37(2):425-9. PubMed ID: 16373632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the benefit of early recanalization sustained at 3 months? A prospective cohort study.
    Labiche LA; Al-Senani F; Wojner AW; Grotta JC; Malkoff M; Alexandrov AV
    Stroke; 2003 Mar; 34(3):695-8. PubMed ID: 12624293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome and resistance to IV thrombolysis in middle cerebral artery ischemic stroke.
    Arenillas JF; Ispierto L; Millán M; Escudero D; Pérez de la Ossa N; Dorado L; Guerrero C; Serena J; Castillo J; Dávalos A
    Neurology; 2008 Jul; 71(3):190-5. PubMed ID: 18625965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic impact of time-point and degree of arterial recanalization of acute middle cerebral artery occlusions after intravenous tPA administration].
    Dorado L; Arenillas JF; Millán M; Pérez De La Ossa N; Guerrero C; Dávalos A
    Med Clin (Barc); 2009 May; 132(16):609-15. PubMed ID: 19376550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new therapeutic strategy for acute ischemic stroke: sequential combined intravenous tPA-tenecteplase for proximal middle cerebral artery occlusion based on first results in 13 consecutive patients.
    Smadja D; Chausson N; Joux J; Saint-Vil M; Signaté A; Edimonana M; Jeannin S; Bartoli B; Aveillan M; Cabre P; Olindo S
    Stroke; 2011 Jun; 42(6):1644-7. PubMed ID: 21527758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of pretreatment blood pressure with tissue plasminogen activator-induced arterial recanalization in acute ischemic stroke.
    Tsivgoulis G; Saqqur M; Sharma VK; Lao AY; Hill MD; Alexandrov AV;
    Stroke; 2007 Mar; 38(3):961-6. PubMed ID: 17255548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and vascular outcome in internal carotid artery versus middle cerebral artery occlusions after intravenous tissue plasminogen activator.
    Linfante I; Llinas RH; Selim M; Chaves C; Kumar S; Parker RA; Caplan LR; Schlaug G
    Stroke; 2002 Aug; 33(8):2066-71. PubMed ID: 12154264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of time to treatment on tissue-type plasminogen activator-induced recanalization in acute ischemic stroke.
    Muchada M; Rodriguez-Luna D; Pagola J; Flores A; Sanjuan E; Meler P; Boned S; Alvarez-Sabin J; Ribo M; Molina CA; Rubiera M
    Stroke; 2014 Sep; 45(9):2734-8. PubMed ID: 25104845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Residual flow signals predict complete recanalization in stroke patients treated with TPA.
    Labiche LA; Malkoff M; Alexandrov AV
    J Neuroimaging; 2003 Jan; 13(1):28-33. PubMed ID: 12593128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator.
    Alexandrov AV; Grotta JC
    Neurology; 2002 Sep; 59(6):862-7. PubMed ID: 12297567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving the predictive accuracy of recanalization on stroke outcome in patients treated with tissue plasminogen activator.
    Molina CA; Alexandrov AV; Demchuk AM; Saqqur M; Uchino K; Alvarez-Sabín J;
    Stroke; 2004 Jan; 35(1):151-6. PubMed ID: 14671245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential pattern of tissue plasminogen activator-induced proximal middle cerebral artery recanalization among stroke subtypes.
    Molina CA; Montaner J; Arenillas JF; Ribo M; Rubiera M; Alvarez-Sabín J
    Stroke; 2004 Feb; 35(2):486-90. PubMed ID: 14707233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prior use of antiplatelet therapy can be associated with a higher chance for early recanalization of the occluded middle cerebral artery in acute stroke patients treated with intravenous thrombolysis.
    Saňák D; Kuliha M; Herzig R; Roubec M; Skoloudík D; Zapletalová J; Köcher M; Král M; Veverka T; Cecháková E; Bártková A; Procházka V; Kaňovský P
    Eur Neurol; 2012; 67(1):52-6. PubMed ID: 22156368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of MRI-based thrombolysis for patients with middle cerebral artery occlusionLi YH; Li MH; Zhao ZG; Bai QK
    Neurol India; 2009; 57(4):426-33. PubMed ID: 19770543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator--treated patients.
    Alvarez-Sabín J; Molina CA; Montaner J; Arenillas JF; Huertas R; Ribo M; Codina A; Quintana M
    Stroke; 2003 May; 34(5):1235-41. PubMed ID: 12677014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.